scholarly article | Q13442814 |
P8978 | DBLP publication ID | journals/neuroimage/WhitfordGFGBHGW06 |
P356 | DOI | 10.1016/J.NEUROIMAGE.2006.03.041 |
P698 | PubMed publication ID | 16677830 |
P5875 | ResearchGate publication ID | 7102885 |
P50 | author | Stuart M. Grieve | Q42434227 |
Tom Farrow | Q42757920 | ||
P2093 | author name string | John Brennan | |
Leanne M Williams | |||
Thomas J Whitford | |||
Lavier Gomes | |||
Evian Gordon | |||
Anthony W F Harris | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 511-519 | |
P577 | publication date | 2006-05-03 | |
P1433 | published in | NeuroImage | Q1981225 |
P1476 | title | Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study | |
P478 | volume | 32 |
Q94348002 | Q94348002 |
Q33525203 | A systematic review of the effects of antipsychotic drugs on brain volume |
Q33296098 | Abnormal oscillatory brain dynamics in schizophrenia: a sign of deviant communication in neural network? |
Q36654213 | Abnormalities of middle longitudinal fascicle and disorganization in patients with schizophrenia |
Q31153621 | Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology |
Q34151554 | Are Bipolar Disorder and Schizophrenia Neuroanatomically Distinct? An Anatomical Likelihood Meta-analysis. |
Q48626810 | Brain differences in first-episode schizophrenia treated with quetiapine: a deformation-based morphometric study |
Q45163957 | Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults |
Q36958178 | Cerebral disconnectivity: an early event in schizophrenia |
Q47221991 | Clinical and neurocognitive course in early-onset psychosis: a longitudinal study of adolescents with schizophrenia-spectrum disorders. |
Q48460836 | Common pattern of gray-matter abnormalities in drug-naive and medicated first-episode schizophrenia: a multimodal meta-analysis. |
Q57464939 | Diverse definitions of the early course of schizophrenia-a targeted literature review |
Q51900054 | Effects of aripiprazole and haloperidol on progression to schizophrenia-like behavioural abnormalities and apoptosis in rodents |
Q34496393 | Excessive extracellular volume reveals a neurodegenerative pattern in schizophrenia onset |
Q34673324 | Fiber pathway pathology, synapse loss and decline of cortical function in schizophrenia |
Q37127470 | Fiber tractography reveals disruption of temporal lobe white matter tracts in schizophrenia |
Q34013842 | G72 influences longitudinal change in frontal lobe volume in schizophrenia |
Q48155090 | Gray matter alterations in first-admission adolescents with schizophrenia |
Q34415975 | Gray matter in first-episode schizophrenia before and after antipsychotic drug treatment. Anatomical likelihood estimation meta-analyses with sample size weighting. |
Q34355445 | Gray matter loss in young relatives at risk for schizophrenia: relation with prodromal psychopathology |
Q57536745 | Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects |
Q34500685 | Inherent Structure-Based Multiview Learning With Multitemplate Feature Representation for Alzheimer's Disease Diagnosis |
Q36807765 | Integrating objective gene-brain-behavior markers of psychiatric disorders |
Q33411428 | Is schizophrenia a neurodegenerative disorder? |
Q37044422 | Is schizophrenia a syndrome of accelerated aging? |
Q41857458 | Is there a degenerative process going on in the brain of people with Schizophrenia? |
Q92319642 | Long-Term Grey Matter Changes in First Episode Psychosis: A Systematic Review |
Q24643949 | Longitudinal brain changes in early-onset psychosis |
Q35592555 | Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation |
Q36247687 | Magnetic resonance imaging correlates of first-episode psychosis in young adult male patients: combined analysis of grey and white matter |
Q33950987 | Morphometric brain abnormalities in schizophrenia in a population-based sample: relationship to duration of illness |
Q30405077 | Oligodendroglial alterations and the role of microglia in white matter injury: relevance to schizophrenia |
Q42279142 | Parietal lobes in schizophrenia: do they matter? |
Q37100414 | Progression of brain volume changes in adolescent-onset psychosis |
Q36395044 | Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia |
Q42182641 | Progressive brain changes in schizophrenia |
Q35898965 | Regional Abnormality of Grey Matter in Schizophrenia: Effect from the Illness or Treatment? |
Q34337272 | Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. |
Q61447355 | Reproducible grey matter patterns index a multivariate, global alteration of brain structure in schizophrenia and bipolar disorder |
Q30475598 | Research in people with psychosis risk syndrome: a review of the current evidence and future directions |
Q34701033 | Similar age-related decline in cortical activity over frontotemporal regions in schizophrenia: a multichannel near-infrared spectroscopy study. |
Q39727461 | Statistical epistasis and progressive brain change in schizophrenia: an approach for examining the relationships between multiple genes. |
Q36117393 | Structural abnormalities in the cuneus associated with Herpes Simplex Virus (type 1) infection in people at ultra high risk of developing psychosis |
Q40547311 | Structural brain changes are associated with response of negative symptoms to prefrontal repetitive transcranial magnetic stimulation in patients with schizophrenia |
Q34393431 | Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis |
Q33721022 | Structural neuroimaging in schizophrenia from methods to insights to treatments |
Q43604840 | Tensor-based morphometry of cannabis use on brain structure in individuals at elevated genetic risk of schizophrenia. |
Q28077138 | The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects |
Q33865677 | The anatomy of first-episode and chronic schizophrenia: an anatomical likelihood estimation meta-analysis |
Q35154166 | The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial |
Q24643935 | The concept of progressive brain change in schizophrenia: implications for understanding schizophrenia |
Q48952912 | The effects of gender on grey matter abnormalities in major psychoses: a comparative voxelwise meta-analysis of schizophrenia and bipolar disorder. |
Q38582714 | The lifetime trajectory of schizophrenia and the concept of neurodevelopment |
Q41535826 | The neurobiology of transition to psychosis: clearing the cache. |
Q48696487 | The optic radiation and the cerebellar peduncles in adolescents with first-admission schizophrenia--a diffusion tensor imaging study |
Q55312155 | The relationship between clinical insight and cognitive and affective empathy in schizophrenia. |
Q48358708 | View-centralized multi-atlas classification for Alzheimer's disease diagnosis |
Q38384706 | fMRI changes over time and reproducibility in unmedicated subjects at high genetic risk of schizophrenia |
Search more.